Cholinergic Receptor, Nicotinic, alpha 6 (CHRNA6) (N-Term) Peptide
CHRNA6
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits CHRNA6
- CHRNA6 (Cholinergic Receptor, Nicotinic, alpha 6 (CHRNA6))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- MLTSKGQGFL HGGLCLWLCV FTPFFKGCVG CATEERLFHK LFSHYNQFIR
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CHRNA6 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- CHRNA6 (Cholinergic Receptor, Nicotinic, alpha 6 (CHRNA6))
- Synonymes
- Acra6 Peptide, Nica6 Peptide, si:dkey-234d14.1 Peptide, CHNRA6 Peptide, cholinergic receptor nicotinic alpha 6 subunit Peptide, cholinergic receptor, nicotinic, alpha polypeptide 6 Peptide, cholinergic receptor, nicotinic, alpha 6 Peptide, Chrna6 Peptide, CHRNA6 Peptide, chrna6 Peptide
- Sujet
-
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Alias Symbols: CHNRA6
Protein Size: 494 - Poids moléculaire
- 57 kDa
- ID gène
- 8973
- NCBI Accession
- NM_004198, NP_004189
- UniProt
- Q15825
-
Vous êtes ici:
